Floriana Camarda

Advanced and recurrent endometrial cancer: state of the art and future perspectives.

G. Scambia, R. Berardi, M. Perri, 2022, Critical reviews in oncology/hematology.

Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data

M. Perri, D. Lorusso, M. V. Carbone, 2023, Cancer management and research.

Recent progress in the use of pharmacotherapy for endometrial cancer

G. Scambia, M. Perri, D. Lorusso, 2022, Expert opinion on pharmacotherapy.

Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: a literature review.

G. Scambia, C. Landolfo, M. Perri, 2021, Critical reviews in oncology/hematology.

PARP Inhibitors Resistance: Mechanisms and Perspectives

G. Scambia, F. Ciccarone, D. Lorusso, 2022, Cancers.